Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cope

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentKathryn A Haynes, Zackery A Cope, Sean-Paul Gerard Williams, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Molecular mechanisms underlying amyloid lowering by aducanumab: differential and comparative effects of sex and IgG reveal the post-treatment disease brainK A Haynes, R S Pandey, E H Doud, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Eclinicalmedicine|December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisTheresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentKathryn A Haynes, Zackery A Cope, Sean-Paul Gerard Williams, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Molecular mechanisms underlying amyloid lowering by aducanumab: differential and comparative effects of sex and IgG reveal the post-treatment disease brainK A Haynes, R S Pandey, E H Doud, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Eclinicalmedicine|December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisTheresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
Pageof 12